Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Moorfields Pharmaceuticals

Moorfields Pharmaceuticals is the manufacturing arm of Moorfields Eye Hospital NHS Foundation Trust. We produce nearly 100 ophthalmic specials and have a growing portfolio of branded licensed products. Moorfields Eye Hospital has provided products in response to clinical needs for over 50 years, from just a handful of pharmacists within the hospital, we now employ more than 75 people.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

Moorfields Pharmaceuticals
25 Provost Street, London, N1 7NH, United Kingdom
+44 (0)20 7684 9090
Contact Moorfields Pharmaceuticals
Website

 Latest Content from PMHub 

PEGASUS SHOWREEL 2017

Videos and Podcasts | June 26, 2017 | Inizio

The new pharma marketing playbook

White Papers and Resources | June 23, 2017 | An agency called Owen

Do you know about the 5 key areas that must be in your pharma marketing playbook?

Pharma needs to evolve from customer-centricity to stakeholder-centricity

White Papers and Resources | June 23, 2017 | An agency called Owen

Customer-centricity and patient-centricity is no longer enough for pharma sales and marketing strategies as digital promises better customer experiences for all pharma stakeholders.

How to plan, execute and refine an excellent congress experience

White Papers and Resources | June 22, 2017 | Blue Latitude Health

Medical congresses are one of the most important and intensive marketing activities a company can undertake. Here, Account Director Dolan Desai and Senior Creative Copywriter Dale Choate give you the...

How can pharma help the NHS capitalise on its data?

White Papers and Resources | June 21, 2017 | Wilmington Healthcare

Sue Thomas, Paul Midgley and Steve How, of Wilmington Healthcare, explain how pharma can work with the NHS to transform services

21st Century Cures Act: a commercial perspective on how the new FDA regulation could revolutionise use of RWE and analytics in healthcare

White Papers and Resources | June 20, 2017 | Blue Latitude Health

The 21st Century Cures Act has transformed the US drug development landscape. David Cooney explores the implications of the Act for pharmaceutical companies and reveals how it can be leveraged.

Using insights to effect behaviour change

Press Releases | June 20, 2017 | Lucid Group Communications Limited

The days when medical communication simply aimed to raise awareness of clinical challenges are well and truly over. In recent years, we have seen a clear shift towards changing physicians’...

Spotlight on Events

Press Releases | June 12, 2017 | Porterhouse Medical Group

Porterhouse has delivered many successful global programmes in 2017 so far. Read about our dedicated events team ...

17 In Search of the Invisible Army

White Papers and Resources | June 8, 2017 | Havas Lynx

The caregivers' story

All five of Lucid’s entries reach the shortlist for Communiqué 2017

Press Releases | June 8, 2017 | Lucid Group Communications Limited

Lucid Group is thrilled to learn that all its entries for the 2017 Communiqué Awards have been shortlisted as finalists! The categories include: Communications Consultancy of the Year Lucid Group   Excellence in Communications via...